SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001683168-23-002817
Filing Date
2023-05-01
Accepted
2023-05-01 17:00:11
Documents
5
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A cns_10ka1-123122.htm 10-K/A 209870
2 CERTIFICATION cns_ex3101.htm EX-31.1 3368
3 CERTIFICATION cns_ex3102.htm EX-31.2 3315
4 CERTIFICATION cns_ex3201.htm EX-32.1 3592
5 CERTIFICATION cns_ex3202.htm EX-32.2 3378
  Complete submission text file 0001683168-23-002817.txt   224549
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

IRS No.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39126 | Film No.: 23874749
SIC: 2834 Pharmaceutical Preparations